approved - International Pharmaceutical Industry

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Volume 16 Issue 1

Electronics and Data, How Effective are Personal Electronics in Helping Patients to Maintain Good Health?

What does the Future Hold for Patients? In Oct 2017 the Adherium stock was trading around AUS $22 with the Rapihaler device FDA approved. Today 2024 – 16 differen...

15 April 2024 Volume 16 Issue 1 | Editorial Archive approved | compliance

Continue Reading →

News

Aptar Pharma’s Preservative-Free Multidose Dispenser Approved for Anti-Allergy Treatment by French Regulatory Agency ANSM

Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved delivery device for Bausch+Lomb’s Levofree Multidose in Franc...